Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
Open Access
- 28 December 2021
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 11 (4) , 922-930
Abstract
Objective: We aim to review the roles of plasmacytoid dendritic cells (pDCs) in head and neck squamous cell carcinoma (HNSCC) and explore the effects of hypoxia on the tolerogenic transformation of pDCs.Background: pDCs, best known as professional type I interferon‐secreting cells, play key roles in immune surveillance and antitumor immunity. Recently, pDCs have been shown to be tolerogenic and correlate with poor prognosis in a variety of cancers, including HNSCC. However, it remains unclear what drives the tolerogenic transformation of pDCs in the HNSCC microenvironment. Hypoxia, a prominent hallmark of the tumor microenvironment (TME) of HNSCC, can interfere with multiple immune cells and establish an immunosuppressive TME.Methods: In this review, we summarize the antitumor and protumor functions of pDCs, explore the effects of hypoxia on the migration and maturation of pDCs, and discuss related mechanisms in HNSCC.Conclusions: pDCs mainly display protumor functions in HNSCC. The hypoxic TME in HNSCC can enhance the migration of pDCs and inhibit the differentiation and maturation of pDCs, promoting the tolerogenic phenotype of pDCs.Keywords
Funding Information
- National Natural Science Foundation of China (91949119, 81670926)
This publication has 80 references indexed in Scilit:
- HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivoBlood, 2012
- Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune EscapeFrontiers in Immunology, 2012
- Continuous Expression of the Transcription Factor E2-2 Maintains the Cell Fate of Mature Plasmacytoid Dendritic CellsImmunity, 2010
- Hypoxia skews dendritic cells to a T helper type 2‐stimulating phenotype and promotes tumour cell migration by dendritic cell‐derived osteopontinImmunology, 2009
- CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and FunctionsThe Journal of Immunology, 2009
- Dendritic cell homeostasisBlood, 2009
- CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host diseaseNature Immunology, 2008
- Tumoricidal activity of TLR7/8-activated inflammatory dendritic cellsJournal of Experimental Medicine, 2007
- Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligandJournal of Experimental Medicine, 2007
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002